IP Library › Granted Patent US 7,074,778
Granted Patent B2
US 7,074,778 · App. 10/148,553 · Granted Jul 11, 2006

Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

Assignee: Genaera Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,074,778
App. No.
10/148,553
Granted
Jul 11, 2006
Kind
B2
Abstract

This invention relates to methods for treating asthma or allergy in a mammal by administering a 3-aminosteroid compound to a mammal in need thereof. The 3-aminosteroid compound being capable of down regulating the IL-9 pathway and alleviating asthmatic responses to allergen. Exemplary 3-aminosteroid compounds used in the methods of the invention include compounds having the chemical formula (I), wherein X, R 1 , R 2 , R 3 , and R 4 groups are as defined herein. The invention also relates to certain novel compounds of formula (I). Moreover, the invention also provides methods for identifying an immunomodulatory 3-aminosteroid compound.

Claims (23)

1. A compound having the formula:

wherein X is selected from the group consisting of —CH 2 —PO(OR 5 ) 2 , —NH—SO 2 —R 5 , —NH—CO—OR 5 , —CH 2 —CO—NH 2 , —CH 2 —CO—NH—R 8 , —CH 2 —CO 2 —R 5 ,

R 1 is selected from the group consisting of R 6 —NH—,

R 2 , R 3 , and R 4 are each independently selected from the group consisting of H, —OAc, and

R 5 is a C 1-12 alkyl;

R 6 is selected from the group consisting of C 1-6 alkyl and phenyl; and

R 7 and R 8 are each independently selected from the group consisting of H, C 1-6 alkyl and phenyl.

2. A method of treating atopic allergy in a mammal comprising administering an effective amount of a 3-aminosteroid compound, wherein said compound has the following chemical formula:

wherein X is selected from the group consisting of —CH 2 —PO(OR 5 ) 2 , —NH—SO 2 —R 5 , —NH—CO—OR 5 , —CH 2 —CO—NH 2 , —CH 2 —CO—NH—R 8 , —CH 2 —CO 2 —R 5 ,

R 1 is selected from the group consisting of R 6 —NH—,

R 2 , R 3 , and R 4 are each independently selected from the group consisting of H, —OAc, and

R 5 is a C 1-12 alkyl; and

R 6 , R 7 and R 8 are each independently selected from the group consisting of H, C 1-6 alkyl, and phenyl.

3. The method of claim 2 , wherein said compound has the following chemical formula

4. The method of claim 2 , wherein said compound has the following chemical formula:

5. A method of treating asthma in a mammal comprising administering an effective amount of the 3-aminosteroid compound, wherein said compound has the following chemical formula:

wherein X is selected from the group consisting of —CH 2 —PO(OR 5 ) 2 , —NH—SO 2 —R 5 , —NH—CO—OR 5 , —CH 2 —CO—NH 2 , —CH 2 —CO—NH—R 8 , —CH 2 —CO 2 —R 5 ,

R 1 is selected from the group consisting of R 6 —NH—,

R 2 , R 3 , and R 4 are each independently selected from the group consisting of H, —OAc, and

R 5 is a C 1-12 alkyl; and

R 6 , R 7 and R 8 are each independently selected from the group consisting of H, C 1-6 alkyl, and phenyl.

6. The method of claim 5 , wherein said compound has the following chemical formula:

7. The method of claim 5 , wherein said compound has the following chemical formula:

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2015
From: GENAERA LIQUIDATING TRUST
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 034835/0287 →
LIQUIDATING TRUST AGREEMENT Recorded Jan 28, 2015
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 034837/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2003
From: LEVITT, ROY C.; NICOLAIDES, NICHOLAS C.; KINNEY, WILLIAM A.; JONES, STEVE
To: GENAERA CORPORATION
Reel/Frame 013792/0654 →
Continuity (2)
Provisional Application 6016995900 · Dec 9, 1999
Related Publication 20030232791A1 · Dec 18, 2003